Albumin depletion of human plasma also removes low abundance proteins including the cytokines

Proteomics

Volumn 5, Issue 18, 2005, Pages 4713-4718

  Granger, Jill ^a,b   Siddiqui, Javed ^a   Copeland, Shannon ^a   Remick, Daniel ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b 2210 Medical Science I Building ^*  (United States)

Author keywords

Albumin; Plasma; Pro inflammatory cytokines; Protein chip; Protein purification

Indexed keywords

ALBUMIN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOASSAY; NONHUMAN; PLASMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PURIFICATION;

CYTOKINES; HUMANS; PLASMA; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SERUM; SERUM ALBUMIN;

EID: 29544441467     PISSN: 16159853     EISSN: None     Source Type: Journal    
DOI: 10.1002/pmic.200401331     Document Type: Article

References (28)

1. Tannapfel, A., Anhalt, K., Hausermann, P., Sommerer, F. et al., J. Pathol. 2003, 201, 238-249.
2. Kaukola, T., Satyaraj, E., Patel, D. D., Tchernev, V. T. et al., Ann. Neurol. 2004, 55, 186-194.
3. Szodoray, P., Alex, P., Brun, J. G., Centola, M., Jonsson, R., Scand. J. Immunol. 2004, 59, 592-599.
4. Anderson, N. L., Anderson, N. G., Mol. Cell Proteomics 2002, 1, 845-867.
5. Rothemund, D. L., Locke, V. L., Liew, A., Thomas, T. M. et al., Proteomics 2003, 3, 279-287.
6. Badock, V., Steinhusen, U., Bommert, K., Otto, A., Electrophoresis 2001, 22, 2856-2864.
7. Herbert, B., Righetti, P. G., Electrophoresis 2000, 21, 3639-3648.
8. Lopez, M., Gutierrez, S., Pluskal, M., Bogdanova, A., Doyle, R. and Pitt, A., Proteome Systems, Millipore 2002.
9. Wells, D., Weil, D., LC GC Europe, Advanstar, Duluth 2003.
10. Sato, A. K., Sexton, D. J., Morganelli, L. A., Cohen, E. H., et al., Biotechnol. Prog. 2002, 18, 182-192.
11. Remick, D. G., Bolgos, G. R., Siddiqui, J., Shin, J., Nemzek, J. A., Shock 2002, 17, 463-467.
12. Mehta, A. I., Ross, S., Lowenthal, M. S., Fusaro, V. et al., Dis. Markers 2003, 19, 1-10.
13. Tirumalai, R. S., Chan, K. C., Prieto, D. A., Issaq, H. J. et al., Mol. Cell. Proteomics 2003, 2, 1096-1103.
14. Knight, P. R., Sreekumar, A., Siddiqui, J., Laxman, B. et al., Shock 2004, 21, 26-30.
15. Travis, J., Bowen, J., Tewksbury, D., Johnson, D., Pannell, R., Biochem. J. 1976, 157, 301-306.
16. Gianazza, E., Arnaud, P., Biochem. J. 1982, 201, 129-136.
17. Gianazza, E., Arnaud, P., Biochem. J. 1982, 203, 637-641.
18. Lollo, B. A., Harvey, S., Liao, J., Stevens, A. C. et al., Electrophoresis 1999, 20, 854-859.
19. Zolotarjova, N., Nicol, G., Martosella, J., Liang-Sheng, L., Zhang, K. and Boyes, B., HPLC poster 2003, Nice France (www.chem.agilent.com).
20. Rengarajan, K., de Smet, M. D., Wiggert, B., Biotechniques 1996, 20, 30-32.
21. Haney, P. J., Draveling, C., Durski, W., Romanowich, K., Qoronfleh, M. W., Protein Expr. Purif. 2003, 28, 270-279.
22. Ahmed, N., Barker, G., Oliva, K., Garfin, D. et al., Proteomics 2003, 3, 1980-1987.
23. Barrett, W., Zolotarjova, N., Chen, H., Mrozinski, P., Szafranski, C., Bailey, J. and Boyes, B., 2004, Agilent Technologies Application, 5989-1347EN (www.chem.agilent.com).
24. Blazer, L., Boyle, M., FASEB J. 2005, 19, Abstract 232 (Experimental Biology Meeting).
25. Daly, M. B., Ozols, R. F., Cancer Cell 2002, 1, 111-112.
26. Quero, C., Colome, N., Prieto, M. R., Carrascal, M. et al., Proteomics 2004, 4, 303-315.
27. Burtis, C., Ashwood, E., Tiez Fundamentals of Clinical Chemistry, Saunders, Philadelphia 2001.
28. Melton, L., Nature 2004, 429, 101-107.